New Horizon Health Limited provided earnings guidance for the six months ended June 30, 2023. For the period, it is expected that the Company will record an adjusted net profit of more than RMB 45 million, as compared to the adjusted net loss of RMB 106.2 million for the same period in 2022. This is the first time for the Company to achieve 12-month adjusted net profits (i.e. from July 1, 2022 to June 30, 2023).

The turnaround from loss to profit of the Company was mainly attributable to: (i) the commercialization progression of the Company's products; and (ii) the expected cost control in respect of, including but not limited to, marketing costs, management costs and R&D costs.